Completed PHASE1 INTERVENTIONAL 2-arm NCT02407340

Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder

Sponsor: Johns Hopkins University

Conditions Alcohol Related Disorders Alcoholism

Updated 8 times since 2017 Last updated: Nov 30, 2017 Started: Mar 31, 2015 Primary completion: Jun 15, 2017 Completion: Jun 15, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02407340, this PHASE1 trial focuses on Alcohol Related Disorders and Alcoholism and remains completed. Sponsored by Johns Hopkins University, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Dec 2017 — Jun 2018 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

Oct 2017 — Dec 2017 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Feb 2017 — Oct 2017 [monthly]

Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE1

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins University

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States